PubRank

E Rowland

Author PubWeight™ 88.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Side effects of long-term amiodarone therapy. Circulation 1983 3.03
2 Echocardiographic measurement of the normal adult right ventricle. Br Heart J 1986 2.16
3 Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study. Br Heart J 1979 2.06
4 Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J 1980 1.64
5 Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. Br Heart J 1983 1.52
6 Catheter ablation for successful management of left posterior fascicular tachycardia: an approach guided by recording of fascicular potentials. Heart 1996 1.47
7 Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features. Br Heart J 1984 1.42
8 Clinical anatomy of the atrioventricular junctions. J Am Coll Cardiol 1994 1.41
9 Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. Br Heart J 1989 1.40
10 Side effects and possible contraindications of amiodarone use. Am Heart J 1983 1.40
11 Successful radiofrequency ablation of accessory pathways with the first energy delivery: the anatomic and electrical characteristics. Eur Heart J 1996 1.38
12 Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995 1.37
13 Rapid and safe termination of supraventricular tachycardia in children by adenosine. Lancet 1987 1.35
14 Amiodarone therapy during pregnancy. Am J Cardiol 1983 1.35
15 Treatment of refractory supraventricular arrhythmias with flecainide acetate. Arch Dis Child 1987 1.28
16 Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol 1984 1.26
17 Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995 1.26
18 The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia. Arch Mal Coeur Vaiss 1978 1.25
19 Low energy catheter ablation of a posteroseptal accessory pathway associated with a diverticulum of the coronary sinus. Pacing Clin Electrophysiol 1991 1.23
20 Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 1980 1.20
21 Endocardial pacing in infants and children 15 kg or less in weight: medium-term follow-up. Pacing Clin Electrophysiol 1990 1.13
22 Electrophysiological manifestations of non-penetrating cardiac trauma. Br Heart J 1980 1.12
23 Concealed pre-excitation. J Electrocardiol 1978 1.11
24 Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999 1.11
25 Radiofrequency catheter ablation of Mahaim tachycardia by targeting Mahaim potentials at the tricuspid annulus. Br Heart J 1995 1.10
26 Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm. Am J Cardiol 1994 1.09
27 Alcohol catheter ablation of atrioventricular conduction. Br Heart J 1991 1.07
28 Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) 1983 1.04
29 Coronary venous aneurysms and accessory atrioventricular connections. Br Heart J 1988 1.00
30 Role of calcium antagonists in cardiovascular therapy. Br Heart J 1981 0.98
31 Dispersion of monophasic action potential duration: demonstrable in humans after premature ventricular extrastimulation but not in steady state. J Am Coll Cardiol 1992 0.97
32 Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J 2002 0.96
33 Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators. J Am Coll Cardiol 1999 0.93
34 Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart 2001 0.92
35 A new low energy power source for catheter ablation. Pacing Clin Electrophysiol 1986 0.92
36 Right ventricular abnormalities in ventricular tachycardia of right ventricular origin: relation to electrophysiological abnormalities. Br Heart J 1986 0.91
37 Histopathological findings in three children with His bundle tachycardia occurring subsequent to cardiac surgery. Eur Heart J 1992 0.90
38 Prediction of atrioventricular block during radiofrequency ablation of the slow pathway of the atrioventricular node. Circulation 1995 0.90
39 Catheter ablation without fulguration: design and performance of a new system. Pacing Clin Electrophysiol 1989 0.89
40 Low-energy ablation of accessory pathways in cases for which the radiofrequency approach had failed. Am J Cardiol 1993 0.89
41 The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. J Hypertens Suppl 1986 0.88
42 Low energy catheter ablation of right ventricular outflow tract tachycardia. Br Heart J 1991 0.88
43 Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart 1996 0.88
44 Primary ventricular fibrillation is associated with increased paced right ventricular electrogram fractionation. Circulation 1995 0.88
45 Atrial pacing as an adjunct to the management of post-surgical His bundle tachycardia. Br Heart J 1991 0.87
46 Local abnormalities of right ventricular depolarization after repair of tetralogy of Fallot: a basis for ventricular arrhythmia. Am J Cardiol 1985 0.86
47 Effect of multisite pacing on ventricular coordination. Heart 2002 0.86
48 Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Eur Heart J 1995 0.86
49 Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris. Am Heart J 1982 0.86
50 Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia. Am J Cardiol 1985 0.86
51 The Wolff-Parkinson-White syndrome: the cellular substrate for conduction in the accessory atrioventricular pathway. Eur Heart J 1994 0.85
52 Dual-demand pacing for refractory atrioventricular re-entry tachycardia. Pacing Clin Electrophysiol 1979 0.85
53 Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J 1997 0.85
54 Long-term follow up of patients treated with a software based antitachycardia pacemaker. Br Heart J 1993 0.84
55 Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. Am J Cardiol 1994 0.83
56 Impedance changes during catheter ablation and their relationship to electrical arcing and clinical efficacy. Pacing Clin Electrophysiol 1989 0.83
57 Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J 1989 0.83
58 Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium. Heart 2001 0.82
59 Comparison between biventricular pacing and single site pacing in patients with poor ventricular function: a hemodynamic study. Pacing Clin Electrophysiol 2003 0.82
60 Intracardiac contrast echoes during transvenous His bundle ablation. Br Heart J 1985 0.82
61 Relation between atrioventricular pathways and ventricular response during atrial fibrillation and flutter. Br Heart J 1981 0.81
62 Electrical restitution in the endocardium of the intact human right ventricle. Br Heart J 1992 0.81
63 Myocardial injury induced by radiofrequency and low energy ablation: a quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol 1998 0.81
64 Clinical competence in electrophysiological techniques. Heart 1997 0.80
65 The tricuspid valve: an unusual site of endocardial pacemaker lead fracture. Pacing Clin Electrophysiol 1989 0.80
66 Maze 3 for atrial fibrillation: two cuts too few? Pacing Clin Electrophysiol 1994 0.80
67 Assessment of a prototype implantable cardioverter for ventricular tachycardia. Relation between synchronisation of sensing and origin of the tachycardia. Br Heart J 1984 0.80
68 Radiofrequency catheter ablation of accessory atrioventricular pathways: primary failure and recurrence of conduction. Heart 1997 0.80
69 Is vagal innervation to the atrioventricular node impaired after radiofrequency ablation of the slow atrioventricular nodal pathway? Pacing Clin Electrophysiol 1996 0.79
70 Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function. Am J Cardiol 1985 0.79
71 Wolff-Parkinson-White syndrome: atrial fibrillation as the presenting arrhythmia. Br Heart J 1988 0.79
72 Relationship of the effective refractory period and monophasic action potential duration after a step increase in pacing frequency. Pacing Clin Electrophysiol 1990 0.78
73 A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation. Br Heart J 1987 0.78
74 Amiodarone for the conversion of established atrial fibrillation and flutter. Br J Clin Pract Suppl 1986 0.78
75 Is the pulse in atrial fibrillation irregularly irregular? Br Heart J 1986 0.78
76 QT dispersion and triple-vessel coronary disease. Lancet 1997 0.77
77 Effects of intravenous adenosine in patients with preexcited junctional tachycardias: therapeutic efficacy and incidence of proarrhythmic events. Am J Cardiol 1994 0.77
78 Electrical ablation of junctional tachycardias showing a long RP interval. Eur Heart J 1989 0.77
79 Performance of basic ventricular tachycardia detection algorithms in implantable cardioverter defibrillators: implications for device programming. Pacing Clin Electrophysiol 1997 0.77
80 Use of flecainide in children. Lancet 1989 0.76
81 'Bradycardia-tachycardia' syndrome 8 yr after correction of Fallot's tetralogy. Eur J Cardiol 1979 0.76
82 Wolff-Parkinson-White syndrome: inadvertent permanent ablation of the accessory pathway during electrophysiological study. Br Heart J 1988 0.75
83 Restrictive transmitral filling patterns predict improvements in left ventricular function after biventricular pacing. Heart 2003 0.75
84 Audit of implantable cardioverter-defibrillators in a single UK centre. BMJ 1999 0.75
85 Latent pre-excitation: exposure of anterograde accessory pathway conduction during atrial fibrillation. Br Heart J 1988 0.75
86 Fifty years of tachycardia. Br Heart J 1995 0.75
87 Successful intracardiac electrical conversion of atrial flutter in patients with complex congenital heart disease. Br Heart J 1991 0.75
88 Endocavitary ablation of atrioventricular conduction. Br Heart J 1990 0.75
89 The automatic implantable cardioverter/defibrillator for a life threatening arrhythmia in a case of post-partum cardiomyopathy. Postgrad Med J 1989 0.75
90 QRS waveforms in right and left bundle-branch aberration. Br Heart J 1980 0.75
91 Familial ventricular tachycardia: a report of four families. Br Heart J 1990 0.75
92 Effects of intravenous dofetilide on induction of atrioventricular re-entrant tachycardia. Heart 2001 0.75
93 Impact of catheter and surgical ablation on arrhythmia treatment in a tertiary referral centre. Br Heart J 1992 0.75
94 Antiarrhythmic drugs--class IV. Eur Heart J 1987 0.75
95 Ablation of atrial flutter using the anatomical method: results and long-term follow-up. J Interv Cardiol 1995 0.75
96 Clinical value of calcium antagonists in treatment of cardiovascular disorders. J Am Coll Cardiol 1983 0.75
97 Long-term effects of amiodarone on hepatic function. Am J Cardiol 1989 0.75
98 Torsade de pointes and nifedipine. Ann Intern Med 1982 0.75
99 Characteristics of bipolar electrograms during anterograde mapping: the importance of accessory atrioventricular pathway location. Am Heart J 1996 0.75
100 Tissue rupture and bubble formation during radiofrequency catheter ablation: "echoes of a pop". Circulation 2001 0.75
101 Late follow-up of catheter ablation of atrial flutter using low-energy direct current. Am J Cardiol 1994 0.75
102 Electrophysiological effects soon after intravenous beta-methyldigoxin. Eur J Cardiol 1979 0.75
103 Atrioventricular junctional reentrant tachycardia utilizing multiple retrograde fibers during ablation of the slow pathway. Clin Cardiol 1993 0.75
104 Amiodarone dose titration: a method to minimise side effects during long term therapy. Br J Clin Pract Suppl 1986 0.75
105 Electrophysiological effects of E 4031, a drug with selective class III properties, in man. Pacing Clin Electrophysiol 1997 0.75
106 The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia. Circ Res 1983 0.75
107 An investigation into the electrical ablation technique and a method of electrode assessment. Pacing Clin Electrophysiol 1986 0.75
108 Adenosine and hypertrophic cardiomyopathy. Lancet 1989 0.75
109 Sudden cardiac death while taking amiodarone therapy: the role of abnormal repolarization. Eur Heart J 1991 0.75
110 Low-energy DC catheter ablation of left atrial ectopic tachycardia that had resulted in reversible cardiomyopathy. Pacing Clin Electrophysiol 1993 0.75
111 Entrapment of an ablation catheter in the cardiac venous system: a case report. Pacing Clin Electrophysiol 1998 0.75
112 Failure to predict development of atrioventricular block with electrophysiological testing supplemented by ajmaline. Pacing Clin Electrophysiol 1980 0.75
113 Antigen and immune complex induced suppression of delayed hypersensitivity. Adv Exp Med Biol 1976 0.75
114 Inappropriate shocks in patients receiving internal cardioverter-defibrillators for malignant ventricular arrhythmias. Indian Heart J 1997 0.75
115 Noninvasive recording of the His bundle electrogram: value of supplementary verapamil. Pacing Clin Electrophysiol 1981 0.75
116 Nonpharmacological treatment of supraventricular tachycardia. Rev Port Cardiol 1992 0.75
117 Ventricular arrhythmias: some pathophysiological aspects and therapeutic problems. G Ital Cardiol 1979 0.75
118 Potassium supplementation in the treatment of ventricular arrhythmias. Acta Med Scand Suppl 1981 0.75